This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
AS "AB CITY" completed the acquisition of an additional 49.19% stake in AS Olainfarm from a group of shareholders for €64.2 million. CI
Olainfarm Board OKs AB City's Mandatory Share Buyback Offer MT
AS Olainfarm : AB City Plans to Initiate Mandatory Repurchase Offer for Olainfarm Shares MT
AS "AB CITY" made an offer to acquire an additional 50.8% stake in AS Olainfarm from a group of shareholders for €66.3 million. CI
Transcript : AS Olainfarm, Q2 2021 Earnings Call, Aug 31, 2021
As Olainfarm Reports Earnings Results for the Half Year Ended June 30, 2021 CI
AS "AB CITY" completed the acquisition of 48.08% stake in AS Olainfarm for ?62.7 million. CI
Janis Buks Elected as the Chairperson of the Management Board of JSC Olainfarm CI
AS "AB CITY" made a mandatory bid to acquire 69.2% stake in AS Olainfarm for ?90.2 million. CI
AS Olainfarm Approves Dividend for the Year 2020, Payable on July 12, 2021 CI
JSC Olainfarm Announces Board Appointments CI
JSC Olainfarm Announces Management Changes CI
JSC “Olainfarm” Elects Audit Committee CI
JSC Olainfarm & Adalvo to Launch New Urology Product in 17 Countries in 2022-2023 CI
Black Duck Invest a.s. agreed to acquire 42.6% stake in AS Olainfarm from SIA Olmafarm for €30 million. CI
Black Duck Invest a.s. completed the acquisition of 42.3% stake in AS Olainfarm from SIA Olmafarm for €30 million. CI
Jeroen Weites Leaves Position as Chairperson of JSC Olainfarm CI
AS Olainfarm Proposes Dividend, Payable on July 12, 2021 CI
Transcript : AS Olainfarm, Q1 2021 Earnings Call, Jun 02, 2021
As Olainfarm Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
JSC Olainfarm Receives an Application from the Current Member of the Management Board Zane Kotane to Resign from May 19 CI
Black Duck Invest Intends to Acquire Stake in Olainfarm CI
Milana Belevica Leaves Her Position as the Member of the Management Board of JSC Olainfarm CI
As Olainfarm Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Olainfarm Considers Participating in Building A Vaccine Manufacturing Plant CI
Chart AS Olainfarm
More charts
Olainfarm AS is a Latvia-based company engaged in the pharmaceutical sector. The Company is active in the production of basic pharmaceutical products and pharmaceutical preparations. The Company's activities include numerous finished forms of medicaments with effects, which include cardiological, neurologic, diuretic, spasmologic and antiallergic drug preparations, medicaments treating the digestive system, antibiotics and food supplements, as well as various active chemical ingredients and raw chemical materials. Its products include Amlodipine, Clonazepam, Euphillin, Furosemide, Furagin, Midolat, Protionol and Gripoflex, among others. The Company operates through its subsidiaries which includes Reinolds SIA, Ozols JDR SIA, Olainfarm energija SIA, Ilmas Aptiekas SIA and Veritas-Farm, among others. In addition, the Company has 33 pharmacies, located in Riga, Vidzeme, Kurzeme and Latgale. In May 2013, it acquired a 47.5% shares in pharmaceutical manufacturer SIA Silvanols.
More about the company
  1. Stock Market
  2. Equities
  3. OLF1R Stock
  4. News AS Olainfarm
  5. Olainfarm Board OKs AB City's Mandatory Share Buyback Offer